Zelira Therapeutics Ltd.ASX: ZLD

Zelira Enters Deal to Develop Products For Vascular Diseases

· Issued by Zelira Therapeutics Ltd.

Filed with ASX · · 6 pages · English

Teleconference at 11am (AEST) Thursday 23 July Conference ID: 10008777. Pre‐registration: https://s1.c‐conf.com/diamondpass/10008777‐invite.html Dial‐in (toll free) Australia: 1800 455 963 (For more dial in options see the bottom of the release) Zelira enters into a commercial agreement to develop products targeting symptoms associated with Peripheral Arterial Disease and Diabetic Neuropathies 22

Zelira Therapeutics Ltd. on 6ix

Earlier from Zelira Therapeutics

Later from Zelira Therapeutics

All Zelira Therapeutics news releases